Research Progress in the Formation and Inhibition Mechanism of Advanced Glycation End Products

被引:1
|
作者
Wu X. [1 ]
Li N. [1 ]
Xu H. [1 ]
Li M. [1 ]
机构
[1] College of Food Science and Engineering, Northwest A&F University, Yangling
来源
Shipin Kexue/Food Science | 2023年 / 44卷 / 17期
关键词
advanced glycation end products; formation; inhibition; metabolism; pathogenesis;
D O I
10.7506/spkx1002-6630-20220903-029
中图分类号
学科分类号
摘要
Advanced glycation end products (AGEs) are a series of stable compounds generated by the nonenzymatic reaction of reducing sugars with proteins, lipids or nucleic acids. It has been found that the excessive accumulation of AGEs in the body can easily cause various chronic diseases such as diabetes, atherosclerosis, Alzheimer’s diseases and cardiovascular diseases. Finding methods to suppress the formation of AGEs is of great significance for ensuring human health. This article summarizes the types, structures, formation process, pathogenesis, and in vivo metabolic pathways of AGEs, with a focus on the methods and mechanisms for the inhibition of AGEs. This review will provide a theoretical basis for controlling the formation of AGEs. © 2023 Chinese Chamber of Commerce. All rights reserved.
引用
收藏
页码:204 / 214
页数:10
相关论文
共 95 条
  • [1] SONG Qinghe, LIU Junjun, DONG Liyuan, Et al., Novel advances in inhibiting advanced glycation end product formation using natural compounds, Biomedicine & Pharmacotherapy, 140, 12, (2021)
  • [2] URIBARRI J, DEL CASTILLO M D, DE LA MAZA M P, Et al., Dietary advanced glycation end products and their role in health and disease, Advances in Nutrition, 6, 4, pp. 461-473, (2015)
  • [3] TWARDA-CLAPA A, OLCZAK A, BIALKOWSKA A M, Et al., Advanced glycation end-products (AGEs): formation, chemistry, classification, receptors, and diseases related to AGEs, Cells, 11, 8, (2022)
  • [4] CEPAS V, MANIG F, MAYO J C, Et al., In vitro evaluation of the toxicological profile and oxidative stress of relevant diet-related advanced glycation end products and related 1,2-dicarbonyls, Oxidative Medicine and Cellular Longevity, 2021, (2021)
  • [5] DAI Jiezhi, CHEN Hua, CHAI Yimin, Advanced glycation end products (AGEs) induce apoptosis of fibroblasts by activation of NLRP3 inflammasome via reactive oxygen species (ROS) signaling pathway, Medical Science Monitor, 25, pp. 7499-7508, (2019)
  • [6] PAN Shuo, GUAN Yitong, MA Yanpeng, Et al., Advanced glycation end products correlate with breast cancer metastasis by activating RAGE/TLR4 signaling, BMJ Open Diabetes Research & Care, 10, 2, (2022)
  • [7] SUZUKI R, FUJIWARA Y, SAITO M, Et al., Intracellular accumulation of advanced glycation end products induces osteoblast apoptosis via endoplasmic reticulum stress, Journal of Bone and Mineral Research, 35, 10, pp. 1992-2003, (2020)
  • [8] AN Xiaofei, ZHANG Lin, YAO Qiuming, Et al., The receptor for advanced glycation endproducts mediates podocyte heparanase expression through NF-κB signaling pathway, Molecular and Cellular Endocrinology, 470, pp. 14-25, (2018)
  • [9] YING Lingwen, SHEN Yun, ZHANG Yang, Et al., Association of advanced glycation end products with diabetic retinopathy in type 2 diabetes mellitus, Diabetes Research and Clinical Practice, 177, (2021)
  • [10] MOLDOGAZIEVA N T, MOKHOSOEV I M, MEL'NIKOVA T I, Et al., Oxidative stress and advanced lipoxidation and glycation end products (ALEs and AGEs) in aging and age-related diseases, Oxidative Medicine and Cellular Longevity, 2019, (2019)